Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Net Cash Flow (2024 - 2025)

Historic Net Cash Flow for Dr Reddys Laboratories (RDY) over the last 3 years, with Q3 2025 value amounting to $8.1 million.

  • Dr Reddys Laboratories' Net Cash Flow fell 8938.66% to $8.1 million in Q3 2025 from the same period last year, while for Dec 2025 it was -$59.3 million, marking a year-over-year decrease of 21890.31%. This contributed to the annual value of $319.0 million for FY2025, which is 2364.34% up from last year.
  • According to the latest figures from Q3 2025, Dr Reddys Laboratories' Net Cash Flow is $8.1 million, which was down 8938.66% from -$67.4 million recorded in Q2 2025.
  • In the past 5 years, Dr Reddys Laboratories' Net Cash Flow registered a high of $76.4 million during Q3 2024, and its lowest value of -$67.4 million during Q2 2025.